ArticleP & T : a peer-reviewed journal for formulary management2011

Azilsartan Medoxomil (Edarbi): The Eighth Angiotensin II Receptor Blocker.

Jocelyn D Jones et al.PubMed ↗Full text ↗

No numbers read from the abstract.